Acurx Pharmaceuticals Inc (ACXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Operating Expenses | 4,123 | 4,378 | 5,115 | 3,115 | 3,445 |
| Operating Income | -4,123 | -4,378 | -5,115 | -3,115 | -3,445 |
| Other Income | 1 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -4,122 | -4,378 | -5,115 | -3,115 | -3,445 |
| Net Income Continuous | -4,122 | -4,378 | -5,115 | -3,115 | -3,445 |
| Net Income | $-4,122 | $-4,378 | $-5,115 | $-3,115 | $-3,445 |
| EPS Basic Total Ops | -5.21 | -5.60 | -7.60 | -4.80 | -5.60 |
| EPS Basic Continuous Ops | -5.21 | -5.66 | -7.58 | -4.79 | -5.65 |
| EPS Diluted Total Ops | -5.21 | -5.60 | -7.60 | -4.80 | -5.60 |
| EPS Diluted Continuous Ops | -5.21 | -5.66 | -7.58 | -4.79 | -5.65 |
| EPS Diluted Before Non-Recurring Items | -5.20 | -5.60 | -7.60 | N/A | N/A |
| EBITDA(a) | $-4,123 | $-4,378 | $-5,115 | $-3,115 | $-3,445 |